No credit card. No commitment.
5000+ G2 reviews
Induced Pluripotent Stem Cell Core Facility
Research
Founded in 2001
Montpellier, OccitanieInduced Pluripotent Stem Cell Core Facility
ResearchFounded in 2001Montpellier, Occitanie
Induced Pluripotent Stem Cell Core Facility's financial review
Induced Pluripotent Stem Cell Core Facility information
Human induced-pluripotent stem (iPS) cells are produced in order to model in a culture dish any monogenic disorders. iPSC technology is a promising breakthrough in regenerative medicine and it was first pioneered by Yamanaka in 2006. By reprogramming somatic cells like fibroblasts and blood cells, iPSC can be generated directly. The SAFE-iPSC facility provides customers with iPSC lines with high ...
Human induced-pluripotent stem (iPS) cells are produced in order to model in a culture dish any monogenic disorders. iPSC technology is a promising breakthrough in regenerative medicine and it was first pioneered by Yamanaka in 2006. By reprogramming somatic cells like fibroblasts and blood cells, iPSC can be generated directly. The SAFE-iPSC facility provides customers with iPSC lines with high viability that can be generated from different cell sources .https://www.chu-montpellier.fr/fr/plateformes-recherche/safe-ips
Induced Pluripotent Stem Cell Core Facility industries
Research
Biotechnology research
Induced Pluripotent Stem Cell Core Facility's financial review
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
